T1	PROC 0 75	Estudio exploratorio de fase Ib/IIa, multicéntrico, abierto, de combinación
T2	PROC 92 157	evaluar la seguridad, farmacocinética, farmacodinámica y eficacia
T3	CHEM 172 180	CC-92480
T4	CHEM 182 192	BMS-986348
T5	PROC 197 223	combinaciones terapéuticas
T6	LIVB 239 252	participantes
T7	DISO 257 273	mieloma múltiple
#1	AnnotatorNotes T7	C0026764; Multiple Myeloma; Neoplastic Process
T8	PROC 303 338	ensayo para determinar la seguridad
T9	CHEM 342 350	CC-92480
T10	CHEM 373 383	compuestos
#2	AnnotatorNotes T10	C0220806; Chemicals; Chemical
T11	LIVB 397 405	personas
#3	AnnotatorNotes T11	C0027361; Persons; Population Group
T12	DISO 410 426	mieloma múltiple
#4	AnnotatorNotes T12	C0026764; Multiple Myeloma; Neoplastic Process
T13	Neg_cue 431 433	no
T14	Negated 434 442	responde
T15	PROC 455 466	tratamiento
#5	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	PROC 507 518	tratamiento
#6	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	DISO 543 559	Mieloma múltiple
#7	AnnotatorNotes T17	C0026764; Multiple Myeloma; Neoplastic Process
T18	DISO 586 590	MMRR
T19	DISO 613 642	Cancer de células plasmáticas
T20	LIVB 672 685	participantes
T21	PROC 787 823	Consentimiento informado por escrito
T22	PROC 851 864	procedimiento
T23	Age 880 889	≥ 18 años
T24	LIVB 941 953	participante
T25	DISO 976 978	MM
#8	AnnotatorNotes T25	C0026764; Multiple Myeloma; Neoplastic Process
T26	DISO 983 993	enfermedad
#9	AnnotatorNotes T26	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T27	DISO 1036 1063	progresión de la enfermedad
#10	AnnotatorNotes T27	C0242656; Disease Progression; Pathologic Function
T28	DISO 1162 1169	Mieloma
#11	AnnotatorNotes T28	C0026764; Multiple Myeloma; Neoplastic Process | C0037930; Spinal Cord Neoplasms; Neoplastic Process
T29	PROC 1245 1256	tratamiento
#12	AnnotatorNotes T29	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T30	DISO 1265 1272	mieloma
#13	AnnotatorNotes T30	C0026764; Multiple Myeloma; Neoplastic Process | C0037930; Spinal Cord Neoplasms; Neoplastic Process
T31	DISO 1293 1304	intolerante
T32	Neg_cue 1307 1309	no
T33	Negated 1314 1323	candidato
T34	PROC 1333 1345	tratamientos
#14	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	DISO 1418 1420	MM
#15	AnnotatorNotes T35	C0026764; Multiple Myeloma; Neoplastic Process
T36	LIVB 1429 1442	participantes
T37	DISO 1455 1473	enfermedad medible
T38	LIVB 1480 1492	participante
T39	PROC 1505 1521	estado funcional
T40	PROC 1661 1691	Plan de Prevención de Embarazo
T41	PROC 1693 1696	PPP
T42	DISO 1738 1748	Compromiso
T43	DISO 1783 1822	compromiso del sistema nervioso central
T44	DISO 1824 1827	SNC
T45	DISO 1832 1834	MM
#16	AnnotatorNotes T45	C0026764; Multiple Myeloma; Neoplastic Process
T46	DISO 1839 1870	Leucemia de células plasmáticas
#17	AnnotatorNotes T46	C0023484; Leukemia, Plasma Cell; Neoplastic Process
T47	DISO 1872 1904	macroglobulinemia de Waldenstrom
#18	AnnotatorNotes T47	C0024419; Waldenstrom Macroglobulinemia; Neoplastic Process
T48	DISO 1906 1932	síndrome de polineuropatía
T49	DISO 1934 1947	organomegalia
#19	AnnotatorNotes T49	C4054315; Organomegaly; Finding
T50	DISO 1949 1963	endocrinopatía
#20	AnnotatorNotes T50	C0014130; Endocrine System Diseases; Disease or Syndrome
T51	DISO 1965 1977	proteína M y
T52	DISO 1978 1996	cambios en la piel
T53	DISO 1998 2003	POEMS
#21	AnnotatorNotes T53	C0085404; POEMS Syndrome; Disease or Syndrome
T54	DISO 2008 2036	amiloidosis de cadena ligera
#22	AnnotatorNotes T54	C0268381; Primary amyloidosis; Neoplastic Process
T55	DISO 2068 2100	Deterioro de la función cardíaca
T56	DISO 2103 2122	enfermedad cardíaca
#23	AnnotatorNotes T56	C0018799; Heart Diseases; Disease or Syndrome
T57	LIVB 2157 2169	participante
T58	DISO 2180 2211	infección previa por SARS-CoV-2
T59	Duration 2222 2233	los 14 días
T60	DISO 2239 2279	infecciones asintomáticas o sintomáticas
T61	Negated 2251 2264	asintomáticas
T62	Duration 2288 2295	28 días
T63	DISO 2301 2313	enfermedades
#24	AnnotatorNotes T63	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T64	Date 2349 2354	día 1
T65	PROC 2390 2397	terapia
#25	AnnotatorNotes T65	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T66	CHEM 2409 2417	CC-92480
T67	PROC 2447 2458	tratamiento
#26	AnnotatorNotes T67	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T68	CHEM 2470 2478	CC-92480
T69	CHEM 2480 2492	tazemetostat
#27	AnnotatorNotes T69	C4086895; tazemetostat; Organic Chemical · Pharmacologic Substance
T70	CHEM 2494 2504	BMS-986158
T71	CHEM 2507 2517	trametinib
#28	AnnotatorNotes T71	C2697961; trametinib; Organic Chemical · Pharmacologic Substance
T72	PROC 2545 2575	alotrasplante de células madre
T73	Date 2579 2596	cualquier momento
T74	PROC 2610 2641	autotrasplante de células madre
T75	Duration 2652 2666	las 12 semanas
T76	PROC 2693 2704	tratamiento
#29	AnnotatorNotes T76	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T77	Duration 2768 2779	los 14 días
T78	PROC 2805 2816	tratamiento
#30	AnnotatorNotes T78	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T79	PROC 2833 2846	Plasmaféresis
#31	AnnotatorNotes T79	C0032134; Plasmapheresis; Therapeutic or Preventive Procedure
T80	PROC 2850 2857	Cirujía
T81	PROC 2872 2884	Radioterapia
#32	AnnotatorNotes T81	C0041626; Ultraviolet Therapy; Therapeutic or Preventive Procedure | C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T82	Neg_cue 2885 2896	distinta de
T83	PROC 2900 2913	terapia local
T84	Negated 2900 2913	terapia local
T85	DISO 2919 2933	lesiones óseas
#33	AnnotatorNotes T85	C0238792; Bone lesion; Disease or Syndrome
T86	DISO 2947 2954	mieloma
#34	AnnotatorNotes T86	C0026764; Multiple Myeloma; Neoplastic Process | C0037930; Spinal Cord Neoplasms; Neoplastic Process
T87	PROC 2975 3000	tratamiento farmacológico
#35	AnnotatorNotes T87	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure
T88	DISO 3013 3022	sistémico
T89	Route 3013 3022	sistémico
T90	CHEM 3040 3063	agente en investigación
T91	Duration 3074 3085	los 28 días
T92	Duration 3088 3102	5 vidas medias
T93	PROC 3146 3157	tratamiento
#36	AnnotatorNotes T93	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T94	CHEM 3175 3190	Vacuna COVID-19
T95	Duration 3201 3212	los 14 días
